The cIMPACT-NOW update 2 [14] specified that the the diagnosis of IDH-mutant astrocytoma can be rendered in the absence of 1p19q testing in case of loss of ATRX nuclear expression on IHC and/or strong, diffuse p54 immunopositivity. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).